These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1350927)

  • 1. Effects of acetorphan, an antidiarrhoeal enkephalinase inhibitor, on oro-caecal and colonic transit times in healthy volunteers.
    Bergmann JF; Chaussade S; Couturier D; Baumer P; Schwartz JC; Lecomte JM
    Aliment Pharmacol Ther; 1992 Jun; 6(3):305-13. PubMed ID: 1350927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea.
    Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
    Gut; 1992 Jun; 33(6):753-8. PubMed ID: 1624154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide.
    Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM
    Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acetorphan, a potent enkephalinase inhibitor, does not modify orocecal and colonic transit times in healthy subjects].
    Baumer P; Akoué K; Bergmann JF; Chaussade S; Nepveux P; Alexandre CL; Schwartz JC; Lecomte JM
    Gastroenterol Clin Biol; 1989 Nov; 13(11):947-8. PubMed ID: 2612837
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study].
    Dorval ED; Regimbeau C; Gamelin E; Picon L; Bérard H
    Gastroenterol Clin Biol; 1995 Jan; 19(1):27-30. PubMed ID: 7720986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an enkephalinase inhibitor on esophageal motility in man.
    Chaussade S; Hamm R; Lecomte JM; Couturier D; Guerre J
    Gastroenterol Clin Biol; 1988 Nov; 12(11):793-6. PubMed ID: 3220232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of refractory diarrhoea in AIDS with acetorphan and octreotide: a randomized crossover study.
    Beaugerie L; Baumer P; Chaussade S; Berard H; Rozenbaum W; Pialoux G; Le Quintrec Y; Schwartz JC; Lecomte JM
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):485-9. PubMed ID: 8804878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetorphan prevents cholera-toxin-induced water and electrolyte secretion in the human jejunum.
    Hinterleitner TA; Petritsch W; Dimsity G; Berard H; Lecomte JM; Krejs GJ
    Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):887-91. PubMed ID: 9355788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
    Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
    Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racecadotril demonstrates intestinal antisecretory activity in vivo.
    Primi MP; Bueno L; Baumer P; Berard H; Lecomte JM
    Aliment Pharmacol Ther; 1999 Dec; 13 Suppl 6():3-7. PubMed ID: 10646045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
    Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
    Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
    Bousselmame R; Eustache M; Michael-Titus A; Costentin J
    Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of telenzepine on gastrointestinal transit: comparison with placebo and domperidone.
    Armbrecht U; Reul W; Stockbrügger RW
    Z Gastroenterol; 1990 Feb; 28(2):85-9. PubMed ID: 2181787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An HPLC assay for sulphapyridine in plasma and its use to assess small bowel transit time after the administration of sulphasalazine.
    Staniforth DH; Coates P; Clarke JG
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):406-9. PubMed ID: 2887521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
    Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats.
    Benouali S; Berard H; Roche M
    Neuropeptides; 1993 May; 24(5):299-305. PubMed ID: 8392143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.